Cartesian Therapeutics Free Cash Flow (Quarterly) Insights

Cartesian Therapeutics Inc (RNAC)

27.19 +2.69 (+10.98%) USD | NASDAQ | May 03, 12:30

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-23.35M
September 30, 2023	-9.215M
June 30, 2023	-9.907M
March 31, 2023	-8.895M
December 31, 2022	-12.06M
September 30, 2022	3.917M
June 30, 2022	-12.37M
March 31, 2022	-12.32M
December 31, 2021	-31.74M
September 30, 2021	-10.91M
June 30, 2021	-6.661M
March 31, 2021	-12.16M
December 31, 2020	-7.44M
September 30, 2020	65.35M
June 30, 2020	-12.01M
March 31, 2020	-11.83M
December 31, 2019	-12.91M
September 30, 2019	-11.13M

Date	Value
June 30, 2019	-7.202M
March 31, 2019	-20.24M
December 31, 2018	-13.12M
September 30, 2018	-16.09M
June 30, 2018	-17.24M
March 31, 2018	-13.60M
December 31, 2017	-12.81M
September 30, 2017	-15.56M
June 30, 2017	-9.015M
March 31, 2017	-15.37M
December 31, 2016	1.374M
September 30, 2016	-5.742M
June 30, 2016	-5.666M
March 31, 2016	-10.31M
December 31, 2015	-7.772M
September 30, 2015	-6.09M
June 30, 2015	-4.743M
March 31, 2015	-5.021M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-31.74M

Minimum

Dec 2021

65.35M

Maximum

Sep 2020

-7.518M

Average

-11.13M

Median

Sep 2019

Free Cash Flow (Quarterly) Benchmarks